Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.27B
-
Number of holders
-
2037
-
Total 13F shares, excl. options
-
1.01B
-
Shares change
-
+152K
-
Total reported value, excl. options
-
$86.2B
-
Value change
-
+$21.2M
-
Put/Call ratio
-
1.09
-
Number of buys
-
1011
-
Number of sells
-
-806
-
Price
-
$84.86
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q3 2021
2,217 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q3 2021.
CVS HEALTH Corp - Common Stock (CVS) has 2,037 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01B shares
of 1.27B outstanding shares and own 79.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (108M shares), BlackRock Inc. (94.6M shares), STATE STREET CORP (55.3M shares), Capital World Investors (50.6M shares), Capital International Investors (27.4M shares), MORGAN STANLEY (22.8M shares), GEODE CAPITAL MANAGEMENT, LLC (21.7M shares), JPMORGAN CHASE & CO (20.2M shares), Invesco Ltd. (18M shares), and BANK OF AMERICA CORP /DE/ (17.2M shares).
This table shows the top 2037 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.